Baidu
map

Developmental Cell:想要伤口好得快,也许活性氧有帮助

2014-10-16 佚名 生物谷

近日,细胞的线粒体产生的“”一直被认为对组织和细胞具有破坏性,而实际上是有利于伤口愈合的。 该结论是加州大学圣地亚哥分校的生物学家发现的,“活性氧”——包含氧气的化学活性分子,如过氧化物,通常被称为自由基——在实验性动物秀丽隐杆线虫体内自由基对皮肤伤口愈合是非常重要的。 在一篇发表在10月13日出版的《细胞发育》杂志中,研究人员发现,线粒体自由基生成不仅是皮肤伤口愈合的必要因素,也增加了活

近日,细胞的线粒体产生的“”一直被认为对组织和细胞具有破坏性,而实际上是有利于伤口愈合的。

该结论是加州大学圣地亚哥分校的生物学家发现的,“活性氧”——包含氧气的化学活性分子,如过氧化物,通常被称为自由基——在实验性动物秀丽隐杆线虫体内自由基对皮肤伤口愈合是非常重要的。

在一篇发表在10月13日出版的《细胞发育》杂志中,研究人员发现,线粒体自由基生成不仅是皮肤伤口愈合的必要因素,也增加了活性氧(ROS)种类的水平,实际上也可以使伤口愈合得更快。

”有很多方法可以生成活性氧细胞,但没有人去研究线粒体中的细节部分,”Andrew Chisholm说,他是加州大学圣地亚哥分校的生物学教授,“我们的发现是令人吃惊的,因为我们没有意识到线粒体在伤口愈合中会起到的重要的作用。”

自由基或活性氧,长期以来被认为是破坏DNA,RNA和蛋白质的凶手。因为这样的氧化损伤被认为是导致过早衰老和癌症的原因,许多人使用抗氧化剂为了减少自由基对细胞的损伤。

但是研究人员发现,虽然细胞中过多的活性氧可能对你有害,但是完全消除活性氧会阻止伤口愈合,至少在蛔虫体内是这样子。他们的发现对开发治疗老年人和糖尿病患者慢性伤口愈合问题的新药物有一定的指导作用。

“看起来你需要一些适当的活性氧,“Chisholm解释道。“太多对你不好,但是太少也不好。我们发现在我们的实验中,当我们敲除在线粒体中产生活性氧的基因同时清除了抗氧化剂,蛔虫的伤口因而不能愈合。我们还发现,只需一点活性氧帮助伤口愈合的速度就会比正常速度要快。”

虽然研究人员已经证实了他们的结论仅仅在低等生物蛔虫体内发生。但是他们猜测该结果适用于高等动物,研究人员正计划进一步对啮齿动物进行实验研究。

“我们怀疑这些基因通路是守恒的,所以它们将会适用于脊椎动物和哺乳动物,”Chisholm说。

原始出处

Xu S1, Chisholm AD2.C. elegans Epidermal Wounding Induces a Mitochondrial ROS Burst that Promotes Wound Repair.Dev Cell. 2014 Oct 13;

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1982209, encodeId=aeb61982209e8, content=<a href='/topic/show?id=13b658e849' target=_blank style='color:#2F92EE;'>#Dev#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5878, encryptionId=13b658e849, topicName=Dev)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcaa382, createdName=fzwish20000, createdTime=Wed Jun 24 20:07:00 CST 2015, time=2015-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1868917, encodeId=5f17186891ed8, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Sat Nov 15 16:07:00 CST 2014, time=2014-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1951979, encodeId=e91919519e914, content=<a href='/topic/show?id=04fa11552da' target=_blank style='color:#2F92EE;'>#Mental#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11552, encryptionId=04fa11552da, topicName=Mental)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920c231, createdName=lixiaol, createdTime=Fri Jan 23 17:07:00 CST 2015, time=2015-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1959162, encodeId=d4e11959162e8, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Wed Jul 15 15:07:00 CST 2015, time=2015-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301367, encodeId=78b3130136e4d, content=<a href='/topic/show?id=b79c6521eb7' target=_blank style='color:#2F92EE;'>#活性氧#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65217, encryptionId=b79c6521eb7, topicName=活性氧)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c2b4297, createdName=徐岩, createdTime=Sat Oct 18 00:07:00 CST 2014, time=2014-10-18, status=1, ipAttribution=)]
    2015-06-24 fzwish20000
  2. [GetPortalCommentsPageByObjectIdResponse(id=1982209, encodeId=aeb61982209e8, content=<a href='/topic/show?id=13b658e849' target=_blank style='color:#2F92EE;'>#Dev#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5878, encryptionId=13b658e849, topicName=Dev)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcaa382, createdName=fzwish20000, createdTime=Wed Jun 24 20:07:00 CST 2015, time=2015-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1868917, encodeId=5f17186891ed8, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Sat Nov 15 16:07:00 CST 2014, time=2014-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1951979, encodeId=e91919519e914, content=<a href='/topic/show?id=04fa11552da' target=_blank style='color:#2F92EE;'>#Mental#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11552, encryptionId=04fa11552da, topicName=Mental)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920c231, createdName=lixiaol, createdTime=Fri Jan 23 17:07:00 CST 2015, time=2015-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1959162, encodeId=d4e11959162e8, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Wed Jul 15 15:07:00 CST 2015, time=2015-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301367, encodeId=78b3130136e4d, content=<a href='/topic/show?id=b79c6521eb7' target=_blank style='color:#2F92EE;'>#活性氧#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65217, encryptionId=b79c6521eb7, topicName=活性氧)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c2b4297, createdName=徐岩, createdTime=Sat Oct 18 00:07:00 CST 2014, time=2014-10-18, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1982209, encodeId=aeb61982209e8, content=<a href='/topic/show?id=13b658e849' target=_blank style='color:#2F92EE;'>#Dev#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5878, encryptionId=13b658e849, topicName=Dev)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcaa382, createdName=fzwish20000, createdTime=Wed Jun 24 20:07:00 CST 2015, time=2015-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1868917, encodeId=5f17186891ed8, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Sat Nov 15 16:07:00 CST 2014, time=2014-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1951979, encodeId=e91919519e914, content=<a href='/topic/show?id=04fa11552da' target=_blank style='color:#2F92EE;'>#Mental#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11552, encryptionId=04fa11552da, topicName=Mental)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920c231, createdName=lixiaol, createdTime=Fri Jan 23 17:07:00 CST 2015, time=2015-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1959162, encodeId=d4e11959162e8, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Wed Jul 15 15:07:00 CST 2015, time=2015-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301367, encodeId=78b3130136e4d, content=<a href='/topic/show?id=b79c6521eb7' target=_blank style='color:#2F92EE;'>#活性氧#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65217, encryptionId=b79c6521eb7, topicName=活性氧)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c2b4297, createdName=徐岩, createdTime=Sat Oct 18 00:07:00 CST 2014, time=2014-10-18, status=1, ipAttribution=)]
    2015-01-23 lixiaol
  4. [GetPortalCommentsPageByObjectIdResponse(id=1982209, encodeId=aeb61982209e8, content=<a href='/topic/show?id=13b658e849' target=_blank style='color:#2F92EE;'>#Dev#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5878, encryptionId=13b658e849, topicName=Dev)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcaa382, createdName=fzwish20000, createdTime=Wed Jun 24 20:07:00 CST 2015, time=2015-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1868917, encodeId=5f17186891ed8, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Sat Nov 15 16:07:00 CST 2014, time=2014-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1951979, encodeId=e91919519e914, content=<a href='/topic/show?id=04fa11552da' target=_blank style='color:#2F92EE;'>#Mental#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11552, encryptionId=04fa11552da, topicName=Mental)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920c231, createdName=lixiaol, createdTime=Fri Jan 23 17:07:00 CST 2015, time=2015-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1959162, encodeId=d4e11959162e8, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Wed Jul 15 15:07:00 CST 2015, time=2015-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301367, encodeId=78b3130136e4d, content=<a href='/topic/show?id=b79c6521eb7' target=_blank style='color:#2F92EE;'>#活性氧#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65217, encryptionId=b79c6521eb7, topicName=活性氧)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c2b4297, createdName=徐岩, createdTime=Sat Oct 18 00:07:00 CST 2014, time=2014-10-18, status=1, ipAttribution=)]
    2015-07-15 维他命
  5. [GetPortalCommentsPageByObjectIdResponse(id=1982209, encodeId=aeb61982209e8, content=<a href='/topic/show?id=13b658e849' target=_blank style='color:#2F92EE;'>#Dev#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5878, encryptionId=13b658e849, topicName=Dev)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bcaa382, createdName=fzwish20000, createdTime=Wed Jun 24 20:07:00 CST 2015, time=2015-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1868917, encodeId=5f17186891ed8, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Sat Nov 15 16:07:00 CST 2014, time=2014-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1951979, encodeId=e91919519e914, content=<a href='/topic/show?id=04fa11552da' target=_blank style='color:#2F92EE;'>#Mental#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11552, encryptionId=04fa11552da, topicName=Mental)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920c231, createdName=lixiaol, createdTime=Fri Jan 23 17:07:00 CST 2015, time=2015-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1959162, encodeId=d4e11959162e8, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Wed Jul 15 15:07:00 CST 2015, time=2015-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1301367, encodeId=78b3130136e4d, content=<a href='/topic/show?id=b79c6521eb7' target=_blank style='color:#2F92EE;'>#活性氧#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65217, encryptionId=b79c6521eb7, topicName=活性氧)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c2b4297, createdName=徐岩, createdTime=Sat Oct 18 00:07:00 CST 2014, time=2014-10-18, status=1, ipAttribution=)]
    2014-10-18 徐岩

相关资讯

Cell Death Dis:活性氧(ROS)的损伤与保护的博弈决定心肌缺血/再灌注的命运

6月19日,自然出版集团子刊Cell Death and Disease在线发表了健康科学研究所杨黄恬研究组题为 “Concentration-dependent wrestling between detrimental and protective effects of H2O2 during myocardial ischemia/reperfusion” 的最新研究成果,揭示了H

日研究发现光线有助于防止感染

  人在受伤后或手术后特别容易感染,特别是药物难以到达的骨组织和关节等部位,病菌容易繁殖,或者变异为耐药性病菌。日本研究人员在动物实验中发现,用光线激活机体自身免疫功能,结合药物就能防止感染。   日本防卫医科大学校等机构的研究人员在新一期网络科学期刊《科学公共图书馆综合卷》上发表报告说,他们在实验中使用的药物在光线照射下会发生化学反应,产生攻击癌细胞和细菌等的活性氧。这种方法此前也被用于治疗一

Cell Stem Cell:干细胞调控和肺癌发展之间有何联系?

目前,加州大学洛杉矶分校(UCLA)Brigitte Gomperts博士带领的研究小组,发现了被认为是肺癌发展的第一阶段的过程的内部活动。这项研究解释了修复肺部组织的成人干细胞生长的调控因子,如何能够引发癌前期病变的形成。这项为期三年的研究,最终会带来新的个体化肺癌治疗方法。肺癌是一种致命的疾病,美国大约29%的癌症死亡是由肺癌引起。      

铁死亡(Ferroptosis):一种新的细胞死亡方式

 Ferroptosis是近年来发现的一种由铁依赖的氧化损伤引起的细胞死亡模式,与凋亡、坏死、自噬不同。 这一死亡过程的标志为细胞质和脂质活性氧增多、线粒体变小以及线粒体膜密度较大。Ferroptosis与谷氨酸引起的兴奋性毒性类似。研究发 现,ferroptosis同细胞凋亡一样受细胞内信号通路的严密调节,这些信号通路包括铁稳态的调节通路、RAS通路以胱氨酸转运通路。对 Ferr

Baidu
map
Baidu
map
Baidu
map